FPMI OTC
FluoroPharma Medical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +100.0%
3Y: +100.0%
5Y: -95.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$44K
+5.3% ▲
Operating Income
-$2M
+30.9% ▲
Net Income
-$2M
+35.2% ▲
EPS (Diluted)
$-0.06
+44.5% ▲
EBITDA
-$744K
+66.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2008 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $166K | $0 | $0 | $0 | $0 |
| YoY Growth | +49.6% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $17K | $0 | $0 | $46K | $44K |
| Gross Profit | $149K | $0 | $0 | -$46K | -$44K |
| Gross Margin | 89.9% | — | — | — | — |
| R&D Expenses | $0 | $1K | $2K | $721K | $511K |
| SG&A Expenses | $162K | $3K | $3K | $2M | $2M |
| Operating Expenses | $326K | $6K | $4K | $3M | $2M |
| Operating Income | -$14K | -$4K | -$5K | -$3M | -$2M |
| Operating Margin | -8.4% | — | — | — | — |
| Interest Expense | $3K | $0 | $0 | $0 | $0 |
| Income Before Tax | -$17K | -$6K | -$4K | -$3M | -$2M |
| Tax Expense | $100 | $2K | $562 | $4 | -$2 |
| Net Income | -$17K | -$7K | -$5K | -$3M | -$2M |
| Net Margin | -10.1% | — | — | — | — |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.11 | $-0.06 |
| EBITDA | -$13K | -$6M | -$4M | -$2M | -$744K |
| Shares Outstanding | 11M | 26M | 29M | 30M | 34M |